CHAIN 1 461 Steroidogenic factor 1.
/FTId=PRO_0000053729.
DNA_BIND 10 85 Nuclear receptor.
ZN_FING 13 33 NR C4-type.
ZN_FING 49 73 NR C4-type.
REGION 230 461 Important for dimerization.
REGION 260 347 Ligand-binding.
BINDING 341 341 Lipid headgroup; via amide nitrogen.
BINDING 436 436 Lipid headgroup.
BINDING 440 440 Lipid headgroup.
MOD_RES 34 34 N6-acetyllysine (Probable).
MOD_RES 38 38 N6-acetyllysine (Probable).
MOD_RES 72 72 N6-acetyllysine (Probable).
MOD_RES 203 203 Phosphoserine; by CDK7.
CROSSLNK 119 119 Glycyl lysine isopeptide (Lys-Gly)
(interchain with G-Cter in SUMO).
CROSSLNK 194 194 Glycyl lysine isopeptide (Lys-Gly)
(interchain with G-Cter in SUMO).
VARIANT 15 15 V -> M (in SRXY3; without adrenal
failure).
/FTId=VAR_063255.
VARIANT 33 33 C -> S (in SRXY3; without adrenal
failure; markedly impaired
transcriptional activity).
/FTId=VAR_039106.
VARIANT 35 35 G -> E (in SRXY3; with adrenal failure).
/FTId=VAR_004737.
VARIANT 78 78 M -> I (in SRXY3; without adrenal
failure).
/FTId=VAR_063256.
VARIANT 84 84 R -> H (in SRXY3; without adrenal
failure; markedly impaired
transcriptional activity).
/FTId=VAR_039107.
VARIANT 91 91 G -> S (in SRXY3; without adrenal
failure).
/FTId=VAR_063257.
VARIANT 92 92 R -> Q (in SRXY3; with adrenal failure).
/FTId=VAR_016982.
VARIANT 123 123 G -> A (in SPGF8 and POF7; activity
levels similar to wild-type).
/FTId=VAR_062967.
VARIANT 129 129 P -> L (in SPGF8 and POF7; loss of
activity).
/FTId=VAR_062968.
VARIANT 131 131 P -> L (in SPGF8; impairs
transactivational activity).
/FTId=VAR_065866.
VARIANT 146 146 G -> A (in dbSNP:rs1110061).
/FTId=VAR_039108.
VARIANT 191 191 R -> C (in SPGF8; impairs
transactivational activity).
/FTId=VAR_065867.
VARIANT 212 212 G -> S (in SPGF8; impairs
transactivational activity).
/FTId=VAR_065868.
VARIANT 231 233 Missing (in POF7).
/FTId=VAR_062969.
VARIANT 238 238 D -> N (in SPGF8; impairs
transactivational activity).
/FTId=VAR_065869.
VARIANT 255 255 R -> L (in ACIWOD).
/FTId=VAR_016983.
VARIANT 293 293 D -> N (in POF7; without adrenal failure;
partial loss of activity).
/FTId=VAR_062970.
VARIANT 437 437 L -> Q (in SRXY3; without adrenal
failure).
/FTId=VAR_063258.
MUTAGEN 119 119 K->R: Loss of sumoylation; when
associated with R-194.
MUTAGEN 194 194 K->R: Loss of sumoylation.
MUTAGEN 269 269 A->F: Strongly reduced transactivation.
MUTAGEN 341 341 G->E: Reduced transactivation. Strongly
reduced transactivation; when associated
with F-344.
MUTAGEN 344 344 L->F: Reduced transactivation. Strongly
reduced transactivation; when associated
with E-341.
MUTAGEN 433 433 A->F: Strongly reduced transactivation.
MUTAGEN 436 436 Y->F: Loss of transactivation; when
associated with A-440.
MUTAGEN 440 440 K->A: Loss of transactivation; when
associated with F-436.
CONFLICT 63 63 K -> N (in Ref. 2; BAA13546).
HELIX 225 233
HELIX 239 243
HELIX 262 282
HELIX 286 288
HELIX 291 317
STRAND 322 324
STRAND 326 328
STRAND 330 332
HELIX 333 339
HELIX 342 360
HELIX 365 376
HELIX 381 383
HELIX 387 408
STRAND 411 413
HELIX 415 442
HELIX 451 456
Back to Top